WASHINGTON (AP) — The Food and Drug Administration announced Friday it will hold a public meeting in October to review the risks of psychiatric and behavioral side effects with Pfizer’s anti-smoking ...

Scientists say the stop-smoking drug should not be a first-line treatment. Nov. 3, 2011— -- Scientists say the U.S. Food and Drug Administration (FDA) should take warnings about the stop-smoking ...

A popular drug prescribed to help people quit smoking may pose a significantly increased risk of heart attack in users, a new study finds. The results may further complicate doctors’ and patients’ ...

Pfizer is recalling batches of the anti-smoking drug Chantix because of a high level of a substance that could increase a user’s risk of developing cancer. The Food and Drug Administration (FDA) says ...

(Reuters) - U.S. health regulators on Friday allowed Pfizer Inc to remove a serious warning from the label of its smoking cessation treatment, Chantix, giving a new lease of life to the controversial ...

On Thursday, Pfizer announced the results of a study of the safety and effectiveness of its Chantix smoking-cessation drug on relapsed smokers. The prognosis was good. Over the course of 12 weeks of ...

WASHINGTON (AP) — Federal regulators say Pfizer has provided low-quality evidence to support its request to remove a bold-letter warning from its anti-smoking drug Chantix about suicidal behavior. The ...

Kicking the habit can be hard enough, but smokers with depression face a steeper challenge. Now there’s evidence that the drug varenincline (Chantix) can help. About half of smokers who try to quit ...